Siewert Type II Adenocarcinoma of Esophagogastric Junction Clinical Trials

8 clinical trials for Siewert Type II Adenocarcinoma of Esophagogastric Junction across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer — RECRUITING
• Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction — RECRUITING · NA
• Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma — RECRUITING · NA
• Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma — SUSPENDED · PHASE2
• A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG — OTHER · NA
• Classification of Adenocarcinoma of the Esophagogastric Junction — OTHER
• Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival — COMPLETED
• Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors — OTHER · NA

Refine this search